Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
A total 40 PD subjects will be included in this study. PD subjects between 20 and 80 years of
age may be eligible for this study. Candidates are screened with a medical history and
physical examination, and blood test.